Cargando…

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy

Detalles Bibliográficos
Autores principales:	Vetrugno, L, Bassi, F, Giordano, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095037/ http://dx.doi.org/10.1186/cc5384

Ejemplares similares

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Cardiogenic shock: an experimental animal model
por: Tanamati, C, et al.
Publicado: (2005)

Effects of levosimendan and inhaled nitric oxide on microcirculation in septic shock
por: Morelli, A, et al.
Publicado: (2009)

Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011)

Effects of levosimendan on renal function in septic shock: a case–control study
por: Morelli, A, et al.
Publicado: (2009)

Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomised controlled study
por: Meddeb, B, et al.
Publicado: (2015)

Utility of brain natriuretic peptide as a marker of early cardiac risk in patients undergoing elective abdominal aortic aneurism repair
por: Vetrugno, L, et al.
Publicado: (2009)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

Hemodynamic and volumetric response to levosimendan in critical care patients
por: Turani, F, et al.
Publicado: (2004)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

BNP and NT-proBNP in patients with acute myocardial infarction complicated by cardiogenic shock: results from the IABP Shock trial
por: Lemm, H, et al.
Publicado: (2010)

Cardiogenic shock in the Aachen Digital Myocardial Infarction Registry
por: Kersten, A, et al.
Publicado: (2007)

Long-term outcome after angioplasty in cardiogenic shock
por: Bulpa, P, et al.
Publicado: (2004)

Intra-aortic balloon counterpulsation: impact on patient hemodynamics in acute myocardial infarction complicated by cardiogenic shock
por: Brazdzionyte, J, et al.
Publicado: (2007)

Mixed and central venous oxygen saturation are not interchangeable in patients with cardiogenic shock after cardiac surgery
por: Romagnoli, S, et al.
Publicado: (2013)

Blood lactate normalization following venoarterial ECMO institution for refractory cardiogenic shock
por: Bottiroli, M, et al.
Publicado: (2015)

Levosimendan: experience of an adult ICU
por: Lippett, S, et al.
Publicado: (2006)

In-hospital and long-term mortality after venoarterial ECMO for refractory cardiogenic shock
por: Bottiroli, M, et al.
Publicado: (2015)

Uncalibrated arterial pulse contour analysis in major vascular surgery
por: Vetrugno, L, et al.
Publicado: (2008)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Copeptin is a strong and independent predictor of outcome in cardiogenic shock
por: Meyer, B, et al.
Publicado: (2009)

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure
por: Zima, E, et al.
Publicado: (2007)

Experiences of a tertiary center with use of extracorporeal membrane oxygenation support in patients with cardiogenic shock after cardiac surgery
por: Galas, L, et al.
Publicado: (2014)

Hemodynamic effects of the new calcium sensitiser levosimendan in cardiosurgical ICU patients
por: Iasonidou, C, et al.
Publicado: (2004)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Induction of mild hypothermia in cardiac arrest survivors with cardiogenic shock syndrome
por: Skulec, R, et al.
Publicado: (2007)

Infections after myocardial infarction and cardiogenic shock and their reflection by inflammation parameters
por: Mitterhammer, H, et al.
Publicado: (2005)

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report
por: Fox, Henrik, et al.
Publicado: (2022)

Value of APACHE II score to predict mortality in cardiogenic shock patients of a cardiologic ICU
por: Ribeiro, M, et al.
Publicado: (2006)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

The PAPIKAS trial: a comparative clinical trial of pulmonary catheter versus the PiCCO device during therapy of patients with acute heart failure and cardiogenic shock
por: Schwab, T, et al.
Publicado: (2010)

Levosimendan in myocardial depression due to severe sepsis
por: Malik, M, et al.
Publicado: (2007)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

Use of levosimendan in myocardial dysfunction due to sepsis
por: Vaitsis, J, et al.
Publicado: (2009)

Haemodynamic effects of levosimendan following cardiac surgery
por: Slezina, A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_aan00fd4g34nchrc7u8h8fddi9